Hoang, T.; Myung, S.-K.; Pham, T.T.; Park, B.
Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials. Cancers 2020, 12, 526.
https://doi.org/10.3390/cancers12030526
AMA Style
Hoang T, Myung S-K, Pham TT, Park B.
Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials. Cancers. 2020; 12(3):526.
https://doi.org/10.3390/cancers12030526
Chicago/Turabian Style
Hoang, Tung, Seung-Kwon Myung, Thu Thi Pham, and Boyoung Park.
2020. "Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials" Cancers 12, no. 3: 526.
https://doi.org/10.3390/cancers12030526
APA Style
Hoang, T., Myung, S.-K., Pham, T. T., & Park, B.
(2020). Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials. Cancers, 12(3), 526.
https://doi.org/10.3390/cancers12030526